Lessons Learned for an OTC Switch from an Rx Professional
Mario Cruz-Rivera, Senior Director of Global Clinical Research & Rx-to-OTC Switch, PFIZER
The Role of Digital Technology in Bridging the Gaps Between Pharmaceutical, Providers, and Consumers
David Lee Scher, MD, FACP, FACC, FHRS, Director, DLS HEALTHCARE CONSULTING
Potential Future OTC Switches From a Pharmacist's Perspective
Daniel Hussar, Ph.D., Remington Professor of Pharmacy, Philadelphia College of Pharmacy, UNIVERSITY OF THE SCIENCES IN PHILADELPHIA
Best Practices to Ensure Label Comprehension and Appropriate Self-Selection for Switch
Bernie Simone, Vice President, Rx-to-OTC Switches, CHATTEM
Cognitive Strategies for Successful Brand Establishment
Terri Goldstein, Chief Executive Officer, THE GOLDSTEIN GROUP
Rx-to-OTC Switch After the Discontinued Lipitor Switch Submission
Steve Francesco, President, FRANCESCO INTERNATIONAL
The Role of Pharmacovigilance as it Relates to OTC Switch
Ariel Abreu-Pena M.D., MBA, Associate Director, Product Vigilance Physician, Consumer Medicinal Products OTC, JOHNSON & JOHNSON PHARMACEUTICALS
